Narrative review / 2013
Hop extract and 8-prenylnaringenin show promise for climacteric symptoms, but clinical evidence on safety and efficacy remains scarce and inconclusive.
This review evaluates hop extracts and specific constituents, notably the estrogenic compound 8-prenylnaringenin (8-PN), for treating menopausal complaints. In vivo studies demonstrate their potential to alleviate symptoms such as osteoporosis, vasomotor complaints, and sexual motivation. However, only a few clinical studies have evaluated menopausal discomforts like hot flushes, yielding rather inconclusive results. The authors note that while 8-PN is only slightly uterotrophic, it shows estrogenic effects on the mammary gland, and safety and efficacy data remain scarce.
- Study type
- Narrative review
- Who was studied
- Menopausal women (clinical studies summarized)
- What was measured
- Climacteric symptoms such as hot flushes and menopausal discomforts
THE PAPER
Hop extracts and hop substances in treatment of menopausal complaints.
Keiler AM, Zierau O, Kretzschmar G. Planta Med, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.